Office of the Commissioner of Lobbying of Canada Office of the Commissioner of Lobbying of Canada

Language selection

Registry of Lobbyists

Patented Medicine Prices Review Board (PMPRB) in Active Registrations on: 2021-11-30

Other options for searching the Registry: 12-Month Lobbying Activity Search; Advanced Registry Search; Recent Registrations; and Recent Monthly Communication Reports.

Results 51-100 of 114

  • Horizon Therapeutics Canada
    Consultant: Stephen Sampson, Global Public Affairs
    Posted date: 2021-08-24
    Submission type: Update View updated registration
  • Canadian Animal Health Institute / Institut canadien de la santé animale
    Consultant: Laura Grosman, HILL + KNOWLTON STRATEGIES
    Posted date: 2021-08-23
    Submission type: New View new registration
  • Canadian Union of Public Employees / Syndicat canadien de la fonction publique
    In-house Organization: Mark Hancock, National President
    Posted date: 2021-08-17
    Submission type: Update View updated registration
  • Amgen Canada Inc.
    In-house Corporation: Brian Heath, General Manager & Vice-President
    Posted date: 2021-08-16
    Submission type: Update View updated registration
  • Life Sciences Ontario (LSO)
    In-house Corporation: Jason Field, President & CEO
    Posted date: 2021-08-13
    Submission type: Update View updated registration
  • Canadian Paediatric Society / Société canadienne de pédiatrie
    In-house Organization: Marie Adèle Davis, Executive Director
    Posted date: 2021-08-13
    Submission type: Update View updated registration
  • Teva Canada Limited / Teva Canada Limitee
    In-house Corporation: Christine Poulin, Senior Vice President and General Manager
    Posted date: 2021-08-13
    Submission type: Update View updated registration
  • McKesson Canada
    In-house Corporation: Rebecca McKillican, CEO
    Posted date: 2021-08-11
    Submission type: Update View updated registration
  • Canadian Health Research Forum (CHRF) / Le forum canadien de la recherche en santé (FCRS)
    Consultant: WILLIAM DEMPSTER, 3Sixty Public Affairs Inc.
    Posted date: 2021-08-09
    Submission type: Update View updated registration
  • The Canada Life Assurance Company / de la Compagnie d'Assurance du Canada sur la Vie
    In-house Corporation: Paul Mahon, President and Chief Executive Officer
    Posted date: 2021-08-09
    Submission type: Update View updated registration
  • Neighbourhood Pharmacy Association
    In-house Organization: Sandra Hanna, Chief Executive Officer
    Posted date: 2021-08-06
    Submission type: Update View updated registration
  • McKesson Canada
    Consultant: Nivitha Jeyakumar, ENsight Canada
    Posted date: 2021-08-05
    Submission type: New View new registration
  • HIV Legal Network / Réseau juridique VIH
    In-house Organization: Sandra Ka Hon Chu, Co-Executive Director
    Posted date: 2021-07-28
    Submission type: Update View updated registration
  • Canadian Pharmacists Association / Association des Pharmaciens du Canada
    In-house Organization: Glen Doucet, Chief Executive Officer
    Posted date: 2021-07-26
    Submission type: Update View updated registration
  • Gilead Sciences Canada Inc.
    Consultant: James Patrick, Proof Strategies Inc
    Posted date: 2021-07-19
    Submission type: New View new registration
  • Gilead Sciences Canada Inc.
    Consultant: Greg Maceachern, Proof Strategies / Proof Stratégies
    Posted date: 2021-07-19
    Submission type: New View new registration
  • Canadian Organization for Rare Disorders
    Consultant: Johanne Chambers, 3Sixty Public Affairs Inc.
    Posted date: 2021-07-16
    Submission type: Update View updated registration
  • CanAge
    In-house Organization: Laura Tamblyn Watts, Chief Executive Officer
    Posted date: 2021-07-06
    Submission type: Update View updated registration
  • Cystic Fibrosis Canada / Fibrose kystique Canada
    In-house Organization: Kelly Grover, President and Chief Executive Officer
    Posted date: 2021-07-06
    Submission type: Update View updated registration
  • The Canadian Lung Association / L'Association pulmonaire du Canada
    In-house Organization: Terrance Dean, President and Chief Executive Officer
    Posted date: 2021-06-30
    Submission type: Update View updated registration
  • Bausch Health, Canada Inc. / Bausch Health, Canada Inc. Solutions de Sante
    In-house Organization: Ginette Gagné, Interim President and General Manager
    Posted date: 2021-06-17
    Submission type: Update View updated registration
  • Cystic Fibrosis Canada / Fibrose kystique Canada
    Consultant: Michelle McLean, Hill+Knowlton Strategies
    Posted date: 2021-06-17
    Submission type: Reactivation View reactivated registration
  • The Ontario Lung Association
    In-house Organization: George Habib, CEO
    Posted date: 2021-06-16
    Submission type: Update View updated registration
  • Sandoz Canada Inc.
    In-house Corporation: Michel Robidoux, President & Chief Executive Officer
    Posted date: 2021-06-04
    Submission type: Update View updated registration
  • Gilead Sciences Canada
    In-house Corporation: Melissa Koomey, V.P. and General Manager
    Posted date: 2021-05-31
    Submission type: Update View updated registration
  • Canadian Generic Pharmaceutical Association (CGPA) / L'Association canadienne du médicament générique (ACMG)
    In-house Organization: JAMES KEON, PRESIDENT
    Posted date: 2021-05-07
    Submission type: Update View updated registration
  • Intellectual Property Institute of Canada / INSTITUT DE LA PROPRIÉTÉ INTELLECTUELLE DU CANADA
    In-house Organization: Adam Kingsley, Chief Executive Officer
    Posted date: 2021-05-05
    Submission type: Update View updated registration
  • Novartis Pharmaceuticals Canada Inc.
    In-house Corporation: Christian Macher, Country President & Oncology General Manager Canada
    Posted date: 2021-05-03
    Submission type: Update View updated registration
  • Lundbeck Canada Inc.
    In-house Corporation: Michal Juul Sørensen, Vice-President & General Manager, Canada
    Posted date: 2021-04-30
    Submission type: Update View updated registration
  • Innovative Medicines Canada
    Consultant: Michelle McLean, Hill+Knowlton Strategies
    Posted date: 2021-04-29
    Submission type: Update View updated registration
  • Innovative Medicines Canada
    Consultant: Don Boudria, Don Boudria Consulting Inc
    Posted date: 2021-04-28
    Submission type: New View new registration
  • RAREi - The Canadian Forum for Rare Disease Innovators / iRARE, le Forum canadien des innovateurs spécialisés dans les maladies rares
    Consultant: Stephanie Levee, 3Sixty Public Affairs Inc.
    Posted date: 2021-04-16
    Submission type: Update View updated registration
  • RAREi - The Canadian Forum for Rare Disease Innovators / iRARE, le Forum canadien des innovateurs spécialisés dans les maladies rares
    Consultant: GERALD JEFFCOTT, 3Sixty Public Affairs
    Posted date: 2021-04-08
    Submission type: Update View updated registration
  • Biogen Canada
    Consultant: Ben Parsons, Counsel Public Affairs Inc.
    Posted date: 2021-04-07
    Submission type: Update View updated registration
  • Biogen Canada
    Consultant: David Murray, Counsel Public Affairs Inc.
    Posted date: 2021-04-07
    Submission type: Update View updated registration
  • Biogen Canada
    Consultant: Sheamus Murphy, Counsel Public Affairs Inc.
    Posted date: 2021-04-07
    Submission type: Update View updated registration
  • Novo Nordisk Canada Inc.
    In-house Organization: Béatrice Clerc, President
    Posted date: 2021-04-06
    Submission type: Update View updated registration
  • Sanofi Pasteur Limited
    In-house Corporation: Fabien Marino, Vice President, Industrial Affairs and Site Head, Toronto
    Posted date: 2021-03-31
    Submission type: Update View updated registration
  • BAYER INC.
    Consultant: Stephen Sampson, Global Public Affairs
    Posted date: 2021-03-24
    Submission type: Update View updated registration
  • AbbVie Corporation
    Consultant: Jodie Kiss, 3Sixty Public Affairs Inc.
    Posted date: 2021-03-23
    Submission type: New View new registration
  • AbbVie Corporation
    Consultant: WILLIAM DEMPSTER, 3Sixty Public Affairs Inc.
    Posted date: 2021-03-22
    Submission type: New View new registration
  • GlaxoSmithKline Inc.
    Consultant: Sheamus Murphy, Counsel Public Affairs Inc.
    Posted date: 2021-03-15
    Submission type: Update View updated registration
  • GlaxoSmithKline Inc.
    Consultant: David Murray, Counsel Public Affairs Inc.
    Posted date: 2021-03-15
    Submission type: Update View updated registration
  • GlaxoSmithKline Inc.
    Consultant: Ben Parsons, Counsel Public Affairs Inc.
    Posted date: 2021-03-15
    Submission type: Update View updated registration
  • Life Sciences Ontario
    Consultant: Philip Delistoyanov, 3Sixty Public Affairs
    Posted date: 2021-03-10
    Submission type: Update View updated registration
  • RAREi - The Canadian Forum for Rare Disease Innovators / iRARE, le Forum canadien des innovateurs spécialisés dans les maladies rares
    Consultant: Johanne Chambers, 3Sixty Public Affairs Inc.
    Posted date: 2021-03-03
    Submission type: Update View updated registration
  • Innovative Medicines Canada
    Consultant: Ikram Farah, Hill & Knowlton Canada
    Posted date: 2021-03-03
    Submission type: New View new registration
  • Innovative Medicines Canada
    Consultant: John Delacourt, Hill+Knowlton Strategies
    Posted date: 2021-03-02
    Submission type: New View new registration
  • Takeda Canada Inc.
    Consultant: Patil Imasdounian, Santis Health
    Posted date: 2021-02-24
    Submission type: Update View updated registration
  • Ipsen Biopharmaceuticals Canada Inc.
    Consultant: WILLIAM DEMPSTER, 3Sixty Public Affairs Inc.
    Posted date: 2021-02-17
    Submission type: Update View updated registration
Return to Government Institutions in Active Registrations
Date Modified: